Glutamine is the body's most abundant amino acid and a key fuel for the gut lining and immune cells. Healthy, well-fed adults are rarely short of it, so routine benefit is modest. The strongest proven benefit applies to sickle cell disease. Generally safe and low-cost, its real-world value is uncertain and best judged against a specific, measurable goal. (Full Review)

Protocol

Maintenance Dose

5–10 g/day

Oral L-glutamine, often divided, for general gut and recovery support

High-Dose Gut Protocol

>30 g/day

For under two weeks around intense training or illness, not chronic high dosing

Dose Splitting

2–3 servings

Improves gastrointestinal tolerance and availability, tied to workouts or meals

Time to effect

Sickle Cell Benefit

Many months

The sickle cell benefit was measured over many months

Gut & Metabolic Effects

A few weeks

Gut-barrier or metabolic effects, where they occur, are typically assessed over a few weeks

GI Tolerance

Immediate

Gastrointestinal tolerance is immediate to judge

Benefits

High: Reduction of acute complications in sickle cell disease

Medium: Preservation of gut barrier under acute stress; lower fasting blood sugar and inflammation marker

Low: Support during recovery from major surgery and burns

Speculative: Reduced sugar cravings via gut-to-brain signaling; immune resilience in healthy, heavily training adults

Contraindications

Active or high-risk cancer (particularly intestinal or liver)

Advanced liver disease with hepatic encephalopathy history (Child-Pugh B–C)

Severe kidney impairment (eGFR < 30 mL/min/1.73 m² or dialysis-dependent)

Critical illness with multi-organ failure

Pregnancy and lactation

Key Interactions

Anticonvulsants (carbamazepine, phenobarbital)

Chemotherapy

Other amino acids sharing transporters

Compromised ammonia clearance (advanced liver disease, dialysis-dependent kidney disease)

Risk & Side Effects

High: Gastrointestinal side effects

Medium: Potential to fuel glutamine-dependent cancers; harm in critically ill patients with organ failure

Low: Ammonia accumulation in hepatic or renal impairment

Speculative: Altered neurotransmitter balance

Monitoring

Marker	Target	Why
eGFR (kidney filtration)	> 90 mL/min/1.73 m²	Screens for kidney impairment that raises ammonia-accumulation risk
Fasting blood glucose	75–85 mg/dL	Identifies metabolic stress where glutamine's blood-sugar signal may matter
hs-CRP (inflammation marker)	< 1.0 mg/L	Tracks the inflammation signal seen in some glutamine trials
ALT/AST (liver enzymes)	< 25 U/L (approx.)	Flags liver impairment relevant to ammonia handling
Blood ammonia	Within lab reference range	Detects metabolite accumulation in at-risk individuals

Cadence: Every 6–12 months for healthy users; every 3–6 months in those with borderline organ function

Qualitative Assessment

Digestive comfort and bowel regularity
Perceived recovery and reduced post-exercise gut distress during heavy training
Frequency of minor infections during high-stress or high-training periods
Overall energy and absence of new adverse symptoms

Glutamine for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment